Document Detail

Randomized trials of clinical networks in the management of ST-elevation MI: can they be performed?
MedLine Citation:
PMID:  19395954     Owner:  NLM     Status:  MEDLINE    
PURPOSE OF THIS REVIEW: Mortality in ST segment elevation myocardial infarction is directly related to the degree of myocardial damage sustained as a result of vessel occlusion. It is well established that the temporal window during which myocardial salvage may be achieved is limited.
RECENT FINDINGS: Prehospital thrombolysis, facilitated percutaneous coronary intervention (PCI) and prompt transfer to institutions with primary PCI capabilities have all been proposed as strategies to augment the temporal window. These different approaches all seek to modify the way reperfusion is delivered, as opposed to the manner of restoring flow, but have been associated with mixed results. Hence, it has become clear that further mortality reductions will require system-based and highly coordinated clinical networks.
SUMMARY: The extent of the mortality benefit associated with the development of an integrated reperfusion network has yet to be established. Collection of robust data in the context of a clinical trial may be obtained by the random allocation of clinical networks as opposed to randomization of patients. Furthermore, such data would be applicable to 'real world' clinical practice, as optimal reperfusion could be examined in patients whose complex comorbidity would preclude their inclusion in conventional ST segment elevation myocardial infarction (STEMI) trials.
Derek P Chew; Lucy J H Blows
Related Documents :
17346124 - The role of coronary angioplasty in the management of patients with stable coronary art...
23853484 - Genetic mutation in korean patients of sudden cardiac arrest as a surrogating marker of...
24098344 - Creatine kinase-overexpression improves myocardial energetics, contractile dysfunction ...
17680854 - Inflammatory cytokine imbalance after coronary angioplasty: links with coronary atheros...
9265434 - Perioperative assessment and management of risk from coronary artery disease.
8507974 - Circulatory assist techniques in cardiogenic shock: metabolic aspects.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in cardiology     Volume:  24     ISSN:  1531-7080     ISO Abbreviation:  Curr. Opin. Cardiol.     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-10     Completed Date:  2010-09-29     Revised Date:  2011-08-25    
Medline Journal Info:
Nlm Unique ID:  8608087     Medline TA:  Curr Opin Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  301-6     Citation Subset:  IM    
Flinders University, Flinders Medical Centre, South Australia, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Balloon, Coronary
Antifibrinolytic Agents / therapeutic use
Community Networks / organization & administration*
Emergency Medical Services
Myocardial Infarction / drug therapy*,  mortality,  therapy
Myocardial Reperfusion*
Randomized Controlled Trials as Topic*
South Australia
Reg. No./Substance:
0/Antifibrinolytic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Resistant hypertension: who and how to evaluate.
Next Document:  The use of early intervention to prevent postoperative complications.